Journal List > Korean J Perinatol > v.24(1) > 1013683

Lee, Park, Kim, Seol, and Park: Blood Urea Nitrogen Concentration and Aggressive Parenteral Amino Acid Administration in Extremely Low Birth Weight Infants during the First Week

Abstract

Purpose :

Early administration of parenteral amino acids has been shown to limit catabolism and improve growth in extremely low birth weight infants (ELBWI). This study aimed to evaluate the relationship between an earlier aggressive administration of amino acids and blood urea nitrogen (BUN).

Methods :

We retrospectively analyzed the medical records of all ELBWI who were born and admitted to Hanyang University Hospital from March 2007 to December 2009. The high initial dose group received ≥3.0 g/kg/d amino acids, while the lower initial dose group did not received a minimum of ≥3.0 g/kg/d parenteral AA at ≤3 days of age.

Results :

There were no differences in gestational age, birth weight and sex between the groups. Mean fluid intake and total calories during the first 48 hours of life were similar between two groups. There is no correlation between amino acid intake and BUN level in ELBWI during study period. However, gestational age showed a significant negative correlation with BUN level in ELBWI on day 3 and 7.

Conclusion :

An earlier, more aggressive administration of amino acids was safe and well-tolerated. There is no correlation between amino acid intake and BUN level in ELBWI infants within 7 days of life.

REFERENCES

1). Adamkin DH. Nutrition in very very low birth weight infants. Clin Perinatol. 1986. 13:419–43.
crossref
2). Bulbul A., Okan F., Bulbul L., Nuhoglu A. Effect of low versus high early parenteral nutrition on plasma amino acid profiles in very low birthweight infants. J Matern Fetal Neonatal Med. 2012. 25:770–6.
crossref
3). Yu VY. Extrauterine growth restriction in preterm infants: importance of optimizing nutrition in neonatal intensive care units. Croat Med J. 2005. 46:737–43.
4). Poindexter BB., Langer JC., Dusick AM., Ehrenkranz RA. Early provision of parenteral amino acids in extremely low birth weight infants: relation to growth and neurodevelop-mental outcome. J Pediatr. 2006. 148:300–5.
crossref
5). Thureen PJ., Melara D., Fennessey PV., Hay WW Jr. Effect of low versus high intravenous amino acid intake on very low birth weight infants in the early neonatal period. Pediatr Res. 2003. 53:24–32.
crossref
6). Porcelli Jr PJ., Sisk PM. Increased parenteral amino acid administration to extremely low-birthweight infants during early postnatal life. J Pediatr Gastroenterol Nutr. 2002. 34:174–9.
7). Thureen PJ. Early aggressive nutrition in very preterm infants. Nestle Nutr Workshop Ser Pediatr Program. 2007. 59:193–204.
crossref
8). Yang S., Lee BS., Park HW., Choi YS., Jeong SH., Kim JH, et al. Effect of High vs Standard Early Parenteral Amino Acid Supplementation on the Growth Outcomes in Very Low Birth Weight Infants. JPEN J Parenter Enteral Nutr. In press. 2012.
9). Kotsopoulos K., Benadiba-Torch A., Cuddy A., Shah PS. Safety and efficacy of early amino acids in preterm <28 weeks gestation: prospective observational comparison. J Perinatol. 2006. 26:749–54.
10). Roggero P., Gianni ML., Morlacchi L., Piemontese P., Liotto N., Taroni F, et al. Blood urea nitrogen concentrations in low-birth-weight preterm infants during parenteral and enteral nutrition. J Pediatr Gastroenterol Nutr. 2010. 51:213–5.
crossref
11). Jobe AH., Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001. 163:1723–9.
crossref
12). Kamitsuka MD., Horton MK., Williams MA. The incidence of necrotizing enterocolitis after introducing standardized feeding schedules for infants between 1250 and 2500 grams and less than 35 weeks of gestation. Pediatrics. 2000. 105:379–84.
crossref
13). Papile LA., Burstein J., Burstein R., Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978. 92:529–34.
crossref
14). Embleton ND. Optimal protein and energy intakes in pre-term infants. Early Hum Dev. 2007. 83:831–7.
crossref
15). Koletzko B., Goulet O., Hunt J., Krohn K., Shamir R. 1. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005. 41(Suppl 2):S1–87.
16). Denne SC., Karn CA., Wang J., Liechty EA. Effect of intravenous glucose and lipid on proteolysis and glucose production in normal newborns. Am J Physiol. 1995. 269:E361–7.
crossref
17). Poindexter BB., Karn CA., Ahlrichs JA., Wang J., Leitch CA., Liechty EA, et al. Amino acids suppress proteolysis independent of insulin throughout the neonatal period. Am J Physiol. 1997. 272:E592–9.
crossref
18). Simmer K. Aggressive nutrition for preterm infants—benefits and risks. Early Hum Dev. 2007. 83:631–4.
crossref
19). Zlotkin SH., Bryan MH., Anderson GH. Intravenous nitrogen and energy intakes required to duplicate in utero nitrogen accretion in prematurely born human infants. J Pediatr. 1981. 99:115–20.
crossref
20). Denne SC., Poindexter BB. Evidence supporting early nutritional support with parenteral amino acid infusion. Semin Perinatol. 2007. 31:56–60.
crossref
21). Ziegler EE., Thureen PJ., Carlson SJ. Aggressive nutrition of the very low birthweight infant. Clin Perinatol. 2002. 29:225–44.
crossref
22). Ibrahim HM., Jeroudi MA., Baier RJ., Dhanireddy R., Krouskop RW. Aggressive early total parental nutrition in low-birth-weight infants. J Perinatol. 2004. 24:482–6.
crossref
23). Ridout E., Melara D., Rottinghaus S., Thureen PJ. Blood urea nitrogen concentration as a marker of amino-acid intolerance in neonates with birthweight less than 1250 g. J Perinatol. 2005. 25:130–3.
crossref
24). Lemons JA., Adcock EW 3rd., Jones MD Jr., Naughton MA., Meschia G., Battaglia FC. Umbilical uptake of amino acids in the unstressed fetal lamb. J Clin Invest. 1976. 58:1428–34.
crossref
25). te Braake FW., van den Akker CH., Wattimena DJ., Huijmans JG., van Goudoever JB. Amino acid administration to premature infants directly after birth. J Pediatr. 2005. 147:457–61.
crossref
26). Clark RH., Chace DH., Spitzer AR. Effects of two different doses of amino acid supplementation on growth and blood amino acid levels in premature neonates admitted to the neonatal intensive care unit: a randomized, controlled trial. Pediatrics. 2007. 120:1286–96.
crossref
27). Hay WW Jr., Lucas A., Heird WC., Ziegler E., Levin E., Grave GD, et al. Workshop summary: nutrition of the extremely low birth weight infant. Pediatrics. 1999. 104:1360–8.
crossref
28). Stephens BE., Walden RV., Gargus RA., Tucker R., McKinley L., Mance M, et al. First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics. 2009. 123:1337–43.
crossref
29). Can E., Bulbul A., Uslu S., Comert S., Bolat F., Nuhoglu A. Effects of aggressive parenteral nutrition on growth and clinical outcome in preterm infants. Pediatr Int. In press. 2012.
30). Blanco CL., Gong AK., Schoolfield J., Green BK., Daniels W., Liechty EA, et al. Impact of early and high amino acid supplementation on ELBW infants at 2 years. J Pediatr Gastroenterol Nutr. 2012. 54:601–7.
crossref

Fig. 1
Mean parenteral amino acid given within 3 days of life. ∗P<0.001 compared to lower initial dose group.
kjp-24-20f1.tif
Fig. 2
BUN concentration vs. the mean intake of parenteral amino acid of the study group at day 3 and 7.
kjp-24-20f2.tif
Fig. 3
BUN concentration vs. gestational age of the study group at day 3 and 7.
kjp-24-20f3.tif
Table 1.
Clinical Characteristics of Study Infants
  High initial dose group (N=17) Lower initial dose group (N=2 9) P-value
Gestational age (wk) 25.7±1.6 25.5±1.0 0.63
Birth weight (g) 805±120 806±125 0.98
Male gender (%) 4 (28.6) 6 (75.0) 0.61
Apgar score at 1min 1.2±0.4 1.2±0.5 0.82
Apgar score at 5min 2.9±0.8 2.8±0.8 0.71
Cesarean section (%) 14 (82) 25 (86) 0.96
Surfactant use (%) 12 (70) 20 (69) 0.54
Fluid intake at first day (mL/kg/day) 82.6±9.9 74.1±21.3 0.13
Fluid intake at day 2 (mL/kg/day) 90.2±16.3 86.0±15.2 0.38
Calorie intake at first day (kcal/kg/day) 44.6±4.8 39.1±15.5 0.21
Calorie intake at day 2 (kcal/kg/day) 52.2±14.9 45.0±18.1 0.15
Breast milk feeding during the first week (%) 10 (59) 18 (62) 0.75
Weight loss (%) 14.0±7.8 15.7±6.3 0.44
Table 2.
Laboratory Data in Study Groups
  High initial dose group (N=17) Lower initial dose group (N=2 29) P-value
Postnatal day 3      
  pH 7.23±0.09 7.24±0.07 0.80
  HCO3 (mEq/dL) 19.1±3.6 18.5±4.0 0.64
  BUN (mg/dL) 39.8±14.1 46.3±13.4 0.13
  NPC/N 87.2±27.3 81.0±28.2 0.49
Postnatal day 7      
  pH 7.23±0.07 7.23±0.08 0.84
  HCO3 (mEq/dL) 18.2±3.7 17.8±4.2 0.76
  BUN (mg/dL) 50.4±32.1 55.3±22.6 0.54
  NPC/N 202.4±238.8 198.9±60.6 0.14
Postnatal day 14      
  BUN (mg/dL) 24.4±9.4 23.2±16.3 0.47
The highest creatinine (mg/dL) in first 7 day 2.3±2.7 1.5±0.4 0.10
Oliguria (1 mL/kg/h) in first 7 day (%) 4 (24) 9 (31) 0.42
Cholestasis (DB>2 mg/dL) in first 7 day (%) 6 (35) 7 (24) 0.31

Abbreviations: BUN, blood urea nitrogen; NPC, non-protein calorie; N, nitrogen; DB, direct bilirubin

Table 3.
Clinical Outcomes of the Study Groups
  High initial dose group (N=17) Lower initial dose group (N=29) P-value
Bronchopulmonary dysplasia (%) 10 (59) 22 (76) 0.18
Necrotizing enterocolitis (%) 3 (18) 5 (17) 0.63
Sepsis (suspected or proven) (%) 10 (59) 24 (82) 0.07
Intraventricular hemorrhage (grade≥3) (%) 2 (14.3) 0 (0) 0.51
Patent ductus arteriosus (%) 11 (78.6) 5 (62.5) 0.62
Patent ductus arteriosus required ligation (%) 2 (12) 7 (24) 0.15
Retinopathy of prematurity (%) 4 (24) 14 (48) 0.08
Retinopathy of prematurity required laser therapy (%) 2 (12) 6 (20) 0.59
Duration of parenteral nutrition (day) 34.0±21.4 46.3±25.6 0.10
Weight at 36 postmenstrual age (g) 1718±307 1840±361 0.32
Length of stay (day) 80.0±47.0 86.2±44.8 0.65
TOOLS
Similar articles